Series A funding round for Rectify Pharmaceuticals raising $100M in October 2021
Series A funding round for Rectify Pharmaceuticals raising $100M in October 2021
| Investor |
|---|
| Firm Type |
|---|
| Partner |
|---|
Omega FundsLEAD | Venture Capital | — |
ForbionLEAD | Venture Capital | — |
Atlas VentureLEAD | Venture Capital | — |
Longwood FundLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$100M
Top Valuation
-
Rectify Pharmaceuticals raised $100M in a Series A round.
The round was announced on 10/01/21.
The round was led by Atlas Venture, Forbion, Longwood Fund, Otello Stampacchia.